Skip to main content

Anthony R. Temple, MD, Recipient of 2014 Distinguished Alumni Award

Anthony R. Temple, MD, was educated in medicine at the University of Utah School of Medicine (’68).  He trained in pediatrics at the children’s service of the Massachusetts General Hospital and the University of Utah Medical Center and Affiliated Hospitals. In 1971, he joined the faculty of the School of Medicine, combining his interests and skills in general pediatrics with his specialty training in medical toxicology. There he taught general pediatrics and became the director of the Intermountain Regional Poison Control Center (now the Utah PCC).

In 1979, he joined the medical department at McNeil Consumer Products, where, in the early 1980s he was instrumental in changing the approach to pediatric dosing of OTC acetaminophen, using a standardized approach he developed, later applying it also to pediatric dosing of OTC ibuprofen. When he retired in 2005, he was vice president, medical affairs. He is widely published and recently published a major analysis of pediatric antipyretic use of acetaminophen.

He was president of the American Association of Poison Control Centers, and on the boards of the American Academy of Clinical Toxicology and the American College of Medical Toxicology. He received the Distinguished Service Award of the AAPCC (1979), the Distinguished Career Achievement Award of the AACT (2003), and the ACMT Award for Excellence in Medical Toxicology (2005).

He has served on the Utah Poison Control Center Advisory Board since 1998. He is now an Adjunct Associate Professor in the University of Utah, Department of Pediatrics, and a resident of St. George, Utah.